Related Experiment Videos
[Rheumatoid arthritis and atherosclerosis]
B Seriolo1, A Sulli, A Burroni
1Clinica Reumatologica, Dipartimento di Medicina Interna e Specialità Mediche, Università di Genova, Genova, Italia. seriolob@unige.it
Reumatismo
|September 27, 2003
Summary
Patients with rheumatoid arthritis (RA) face higher cardiovascular disease risks. Underlying factors like inflammation and specific biomarkers contribute to this increased risk, necessitating further research.
Area of Science:
- Rheumatology
- Cardiovascular Medicine
- Immunology
Context:
- Rheumatoid arthritis (RA) is associated with a significantly increased risk of cardiovascular disease (CVD) and mortality.
- The precise risk factors for coronary artery disease (CAD) in RA patients remain incompletely understood.
- Existing research suggests multifactorial contributors to atherogenesis in RA.
Purpose:
- To explore the multifaceted risk factors contributing to cardiovascular disease in rheumatoid arthritis patients.
- To elucidate the role of inflammation and specific biomarkers in RA-associated cardiovascular complications.
- To identify key factors influencing atherogenesis in the context of rheumatoid arthritis.
Summary:
- Accumulating evidence links rheumatoid arthritis (RA) to elevated risks of cardiovascular disease (CVD) and mortality.
- Potential risk factors include elevated homocysteine, antiphospholipid antibodies, altered lipoproteins, corticosteroid use, methotrexate, and hormonal factors.
- The inflammatory process inherent in RA is increasingly recognized as a contributor to atherosclerosis, with elevated pro-inflammatory cytokines correlating with future coronary events.
Impact:
- Highlights the critical need for comprehensive cardiovascular risk assessment in RA patients.
- Suggests potential therapeutic targets by identifying key atherogenic factors in RA.
- Emphasizes the link between chronic inflammation and cardiovascular pathology, relevant to other inflammatory diseases.